US Stocks
/
Vaxcyte, Inc. Share Price
Vaxcyte, Inc. Share Price

Vaxcyte, Inc. Share Price

NASDAQ: PCVX | Mid Cap
$61.45
+$0.94 (1.55%) Last updated on 29 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Vaxcyte, Inc. Stock Performance

Open
$60.20
Prev. Close
$60.51
Circuit Range
N/A
Day Range
$59.91 - $61.79
Year Range
$39.91 - $90.08
Volume
1,51,907
Average Traded
$61.02

Vaxcyte, Inc. Share Price Today

As of 29 October 2026, Vaxcyte, Inc.'s share price is $61.45. The stock opened at $60.20, compared to its previous close of $60.51. During today's trading session, Vaxcyte, Inc.'s share price traded between $59.91 and $61.79, with an average price of $60.85. Over the past 52 weeks, the stock has recorded a high of $90.08 and a low of $39.91. In terms of performance, Vaxcyte, Inc.'s share price has risen by 7.27% over the last six months and is up 35.72% on a year-on-year basis.

Vaxcyte, Inc. Share Price Chart

$59.91$61.79
L
Show Current Price
H

Vaxcyte, Inc. Stock Fundamentals & Key Indicators

Market Cap
$8.36B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-6.76
Revenue (TTM)
$0.00
Return On Equity (TTM)
-38.59%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-33.58%

Vaxcyte, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$212.83-$246.51-$320.62-$284.30
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-15.82%-30.06%11.33%

Vaxcyte, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$223.49-$402.27-$463.93-$766.63
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-79.99%-15.33%-65.25%

About Vaxcyte, Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Vaxcyte, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$56.89
$61.45
+7.81%
Sep 2026
$60.85
$57.00
-6.73%
Aug 2026
$54.01
$61.12
+13.03%
Jul 2026
$58.02
$54.07
-6.94%
Jun 2026
$50.45
$58.10
+12.98%
May 2026
$56.91
$51.42
-10.22%
Apr 2026
$58.69
$57.28
-1.34%
Mar 2026
$60.14
$58.06
-5.93%
Feb 2026
$53.59
$61.72
+15.11%
Jan 2026
$46.31
$53.62
+16.31%
Dec 2025
$44.98
$46.10
-6.84%
Nov 2025
$45.13
$49.48
+9.30%

PCVX Share Price FAQs

What is Vaxcyte, Inc. share price today?

chevron-up
Vaxcyte, Inc. share price today is $61.45 as on October 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Vaxcyte, Inc. stock?

chevron-up
The 52 week high of Vaxcyte, Inc. stock is $90.08, while the 52 week low is $39.91 as of 29 Oct '26.

What is PCVX's market capitalisation today?

chevron-up
PCVX market capitalisation is $8.36B as of October 29, 2026, at 4:52 am IST.

What is PCVX's net income for the last quarter?

chevron-up
PCVX's net income for the last quarter is -284.30B USD.

What is the 5 year returns of PCVX?

chevron-up
The 5 year returns of PCVX is 162.59% as on 29 Oct '26.

What is the high & low stock price of PCVX today?

chevron-up
PCVX stock price hit a high of $61.79 and low of $59.91 as of 29 Oct '26.

Can I buy PCVX shares in India?

chevron-up
Yes. You can buy PCVX in India by opening an international trading account.